Skip to content

Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children

Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02821260
Acronym
PEPSI
Enrollment
500
Registered
2016-07-01
Start date
2015-12-31
Completion date
2028-09-30
Last updated
2023-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The Pediatric Neurosurgery Service of the Rothschild Foundation (Paris) is the French leader center for surgery of epilepsy in infants and children. Postoperative follow-up of these children is performed during medical and neurosurgical consultations in order to assess the frequency of attacks and to reduce medication. On average, two postoperative consultations are carried out between 3 and 5 months and between 12 and 18 months. Beyond 18 months, some children may benefit from long-term monitoring at this center, but most children are followed by their neurologist . Therefore, the center has no rigorous and systematic collection of standardized data on the outcome of these patients. The purpose of this study is to evaluate the efficacy of the epilepsy surgery in children with a monitoring of 3 years.

Interventions

None listed

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Child treated surgically for epilepsy at the Rothschild Foundation (Paris, France)

Exclusion criteria

* Parental opposition to the participation of their child to the study

Design outcomes

Primary

MeasureTime frame
Number of seizuresThree years

Countries

France

Contacts

Primary ContactChristine BULTEAU, MD
cbulteau@fo-rothschild.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026